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Background: FK506 is an important immunosuppressant, which can be produced by Streptomyces tsukubaensis.
However, the production capacity of the strain is very low. Hereby, a computational guided engineering approach
was proposed in order to improve the intracellular precursor and cofactor availability of FK506 in S. tsukubaensis.
Results: First, a genome-scale metabolic model of S. tsukubaensis was constructed based on its annotated genome
and biochemical information. Subsequently, several potential genetic targets (knockout or overexpression) that
guaranteed an improved yield of FK506 were identified by the recently developed methodology. To validate the
model predictions, each target gene was manipulated in the parent strain D852, respectively. All the engineered
strains showed a higher FK506 production, compared with D852. Furthermore, the combined effect of the genetic
modifications was evaluated. Results showed that the strain HT-ΔGDH-DAZ with gdhA-deletion and dahp-, accA2-,
zwf2-overexpression enhanced FK506 concentration up to 398.9 mg/L, compared with 143.5 mg/L of the parent
strain D852. Finally, fed-batch fermentations of HT-ΔGDH-DAZ were carried out, which led to the FK506 production
of 435.9 mg/L, 1.47-fold higher than the parent strain D852 (158.7 mg/L).
Conclusions: Results confirmed that the promising targets led to an increase in FK506 titer. The present work is the
first attempt to engineer the primary precursor pathways to improve FK506 production in S. tsukubaensis with
genome-scale metabolic network guided metabolic engineering. The relationship between model prediction and
experimental results demonstrates the rationality and validity of this approach for target identification. This strategy
can also be applied to the improvement of other important secondary metabolites.
Keywords: Streptomyces tsukubaensis, FK506, Genome-scale metabolic model, Target prediction, Metabolic
engineering, Combinatorial modificationBackground
FK506 (tacrolimus), which is produced by Streptomyces
tsukubaensis, is a 23-membered polyketide macrolide
(Figure 1A). It has been used as an immunosuppressant
after the transplantation of allogeneic kidney, liver and
bone marrow as well as for the treatment of inflamma-
tory skin diseases and eczema [1-3]. FK506 structural
cluster contains polyketide synthase (PKS) and non-
ribosomal peptide synthetase (NRPS) (Figure 1B), which* Correspondence: jpwen@tju.edu.cn
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reproduction in any medium, provided the orbelongs to an amide bond-containing macrolide family
with ascomycin and rapamycin [4-7]. PKS is responsible
for assembling specific carboxylic acid-derived extender
units into polyketide chains and catalyzing subsequent
reductive reactions. NRPS incorporates various amino
acids or amino acid derivatives into non-ribosomally
synthesized peptides.
Recently, tremendous efforts based on the random
mutagenesis and selection approaches have been dedi-
cated to the development of efficient FK506 synthesis.
As a major bottleneck, the FK506 yield in fermentation
process is relatively low, which may be due to the
limited level of intracellular precursors. Thus, it is essen-
tial to engineer the strain to improve the requirement of
precursors for product formation. Indeed, metabolicLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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Figure 1 Structures and biosynthetic gene cluster of FK506 and byproducts (FK520, FK506D) in S. tsukubaensis. (A) Structures of FK506
and byproducts FK520, FK506D. The allyl side chain at C-21 of FK506 is replaced by an ethyl group in FK520 and a propyl group in FK506D.
(B) Schematic representation of FK506 and analogues (FK520, FK506D) biosynthetic gene cluster in S. tsukubaensis.
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precursors have regulated the key pathways of natural
products such as polyketide and polypetide. For example,
it was reported that overexpression of propionyl-CoA
carboxylase, methylmalonyl-CoA mutase, and malonyl/
methylmalonyl-CoA ligase led to the accumulation of
methylmalonyl-CoA, a key precursor of FK506 [8]. Be-
sides, the precursor pathway enhancement has been
performed by strengthening the supply of unusual polyke-
tide extender units [9].
Genetic manipulations may improve the precursor syn-
thesis and product titer. Nevertheless, the approach is al-
ways uncertain and blind for target genes validation.
Additionally, as cells have highly interconnected metabolic
pathways, overexpression or knockout of the specific
pathway may generate an effect on other pathways and
subsequently on the cell growth. Importantly, since the
scope of engineering is local, there may exist some limita-
tions for strain improvement. Therefore, it is challenging
to evaluate the cellular behaviors comprehensively andidentify the accurate target genes for efficient strain im-
provement from the systems-level.
Developed by the techniques such as flux balance ana-
lysis (FBA) and minimization of metabolic adjustment
(MOMA), systems biology plays an important role in
strain metabolic engineering by changing metabolic flux
distribution within a microorganism based on systematic
strategies. As more microorganisms have been sequenced,
the reconstruction of a genome-scale metabolic model
(GSMM) becomes necessary in gaining comprehensive
insight into microbial physiology [10]. Stoichiometric
models-based GSMM can be employed to interpret cellu-
lar metabolic response to genetic perturbation and unravel
the underlying reasons of undesired phenotypes. This
approach saves time, labor, and research expenditure by
decreasing the amounts of wet-experiments. Currently,
GSMMs have been used to identify metabolic engineer-
ing targets for many important industrial products such
as biofuels, vitamins, amino acids and secondary metab-
olites [11-14].
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algorithms, such as MOMA, ROOM, OptKnock, OptReg,
OptORF, RobustKnock, OptStrain and OptForce have
been developed to efficiently predict target genes for
improved product yield [15-22]. Among the above ap-
proaches, intracellular flux distribution can be calculated
by maximization of cell biomass or minimization of meta-
bolic adjustments. The calculated results which largely re-



































































































































Figure 2 Schematic representation of metabolic pathways for S. tsuku
green (amplification) and red (knockout). The shaded boxes represent precused to inactivate the target pathways for improved
production. In addition to the knockout prediction, the
overexpression prediction algorithm has also been re-
cently developed to direct application of product overpro-
duction [23,24].
In this study, a GSMM of S. tsukubaensis was re-
constructed to simulate the intracellular flux distribu-
tion. Guided by FBA and MOMA prediction, several






































































baensis. The predicted targets for improved production are shown in
ursors of FK506 biosynthesis.
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then screened and validated experimentally through meta-
bolic engineering as well as subsequent batch fermenta-
tions. Moreover, the gene knockout and overexpression
combinatorial strategy was implemented to enhance the
FK506 production up to 435.9 mg/L of final titer, an ap-
proximately 2-fold increase relative to the parent strain.
Results
GSMM reconstruction for S. tsukubaensis
The first genome sequence draft of the FK506 producer,
S. tsukubaensis NRRL 18488 has been reported recently
[25]. In the present work, GSMM was reconstructed
using an automated procedure as well as manual refine-
ment (see Materials and methods section). By integrating
the genome annotation results, a draft model including
865 reactions and 621 metabolites was obtained. Here,
the biomass composition was obtained by integrating
the corresponding results related to other Streptomyces
from experiments and references. The energetic coeffi-
cients for both cell growth and maintenance were also
evaluated based on the previous report [26].
Major metabolic pathways for S. tsukubaensis, includ-
ing the glycolytic pathway, pentose phosphate pathway
(PPP), tricarboxylic acid (TCA) cycle, and FK506 biosyn-
thesis, are illustrated in Figure 2. Additionally, the details
of the biosynthetic pathways for FK506 precursors are
also presented (Additional file 1: Text S1, Additional file
2: Text S2). It can provide some advantages about how
carbon is diverted to these pathways, thus resulting in
an efficient FK506 production in S. tsukubaensis.
Potential target genes identification based on in silico
simulations
Gene knockout simulation
First, FK506 was assumed as the extracellular metabolite
here for convenient calculation, although it belonged to
the intracellular product. Then the experimental specific
production rate of FK506 was determined to be 1.61 ±
0.10 μmol/g DCW/h and was set as the lower bound for
FK506 transport flux. In this work, glucose was not
implemented as the principal carbon source during the
in silico calculation due to the fact that S. tsukubaensis
could not produce the high efficient of FK506 in
glucose-based medium. Instead, our previous experi-
ences proved that starch was beneficial to FK506
production. Since the carbon source (starch) harbored
long-chain whose molecular formula was uncertain, the
specific uptake rate of carbon source was defined as the
production rate of glucose-1-phosphate derived from
starch which was 3.472 mmol/g DCW/h. The upper
bound of the specific uptake rates of twenty L-amino
acids was set to 0.050 mmol/g DCW/h based on our ex-
perimental data (the specific consumption rates of allamino acids were between 0 and 0.050 mmol/g DCW/h
during initial exponential growth phase and late exponen-
tial growth phase). Using these experimental constrains,
the specific growth rate was predicted to be 0.0495 h-1,
consistent with the experimental data (0.0502 h-1). For a
higher productivity of FK506, potential gene knockout
targets were identified by MOMA algorithm (Figure 3A).
Initially, several single gene knockouts were identified.
Here, we discussed the cases that specific growth rate
was more than 0.04 h-1. Among these promising target
genes, the gene aceB2/B1 or aceA, was predicted to in-
activate the glyoxylate shunt and thus avoided the con-
sumption of acetyl-CoA. The flux from acetyl-CoA to
biomass was partially diverted towards the precursors of
FK506 biosynthesis. As shown in Figure 2, acetyl-CoA
can be transformed to malonyl-CoA and subsequently
allylmalonyl-CoA, both of which are the direct precur-
sors of FK506. Deletion of sucC/D could result in a re-
duction of the TCA cycle activity, thereby reducing the
consumption of the acetyl-CoA pool and indirectly
enhancing the precursors supply (malonyl-CoA and
allylmalonyl-CoA). Knockout of pgi gene could divert
the carbon flux from glycolytic pathway to PPP, which
would improve the NADPH availability, since the FK506
biosynthesis need many NADPH (Figure 2, Additional
file 2: Text S2). In the following analysis, sucC/D was
excluded from knockout candidates. Although blocking
the TCA cycle at succinyl-CoA synthase can indirectly
affect the carbon flows towards the methylmalonyl-CoA
pool, it also results in two fewer moles of ATP. Add-
itionally, aceA or aceB2/B1 or pgi was not selected be-
cause the level of FK506 enhancement and cell growth
were not the optimal. Therefore, after removing these
targets, gdhA and ppc were selected as candidates for
the following experimental validation as they both
allowed an increased specific FK506 production rate
with less reduction in the specific growth rate. The
gdhA gene directly impact the supply of FK506 redox
cofactor since its deletion could increase the availability
of NADPH [27] for other NADPH coupled enzymes
such as ketoreductase and enoylreductase. This strain
optimization strategy not only increased FK506 produc-
tion rate by approximately 80%, up to 3.05 μmol/g
DCW/h, compared with the wild type (1.61 μmol/g
DCW/h), but also exerted a small effect on cell growth
(the maximum growth rate of 0.0455 h-1). Another
screened target was ppc gene encoding the phosphoenol-
pyruvate carboxylase (PPC). Inactivation of ppc gene
would directly enhance the phosphoenolpyruvate (PEP)
pool, thus providing more precursors to synthesize 4,5-
dihydroxycyclohex-1-enecarboxylic acid (DHCHC, starter
of FK506 formation, Figure 2). Noted that although initial
metabolic flux distribution in FBA simulation were un-
determined, the in silico prediction for targets was unique.






































































































































































































































Figure 3 Single gene knockout, overexpression and knockout-overexpression combinations target identification in S. tsukubaensis.
(A) The effect of single gene knockout on the specific FK506 production rate and the specific growth rate. (B) The effect of single gene
overexpression on the specific FK506 production and fPH. (C) The effect of knockout-overexpression combinations on the specific FK506
production and fPH. The enzymes encoded by these genes are as follows: aceA, isocitrate lyase; aceB2/B1, malate synthase; sucC/D, succinyl-CoA
synthase; gdhA, glutamate dehydrogenase; pgi, glucose-6-phosphate isomerase; ppc, phosphoenolpyruvate carboxylase; dahp, 3-deoxy-D-arabino-
heptulosonate-7-phosphate synthase; pntAB, pyridine nucleotide transhydrogenase; accA2, acetyl-CoA carboxylase; fkbA, fkbB, fkbC, polyketide
synthase; fkbO, chorismatase, 4,5-dihydroxycyclohex-1-enecarboxylic acid (DHCHC) synthesis; fkbL, lysine cyclodeaminase; fkbP, non-ribosomal
peptide synthetase; fkbM, 31-O-methyltrasferase; fkbD, C9 hydroxylase; fkbG, fkbH, fkbI, fkbJ, fkbK, genes for methoxymalonyl-ACP synthesis; tcsA,
tcsB, tcsC, tcsD, genes for allymalonyl-CoA synthesis; zwf2, glucose-6-phosphate dehydrogenase; pccB, propionyl-CoA carboxylase; metK,
S-adenosylmethionine synthetase.
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olite production could be improved by balancing the
precursors and lowering the growth rate [11]. This
insight into the S. tsukubaensis metabolism offered a
mechanism of how this strain was redesigned towards
efficient FK506 synthesis.Gene overexpression simulation
Using the fPH, overexpression targets for improving
FK506 production were identified [24]. Figure 3B shows
the fPH of several important reactions leading to FK506
overproduction. Among these targets, dahp had the
highest ratio (fPH =11.5), indicating that increasing
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production. In fact, the primary shikimate pathway
played a key role in the supply of precursor chorismate,
which was used as the amino donor in DHCHC biosyn-
thesis [28]. The second target suggested that an increase
in NADPH biosynthesis may accommodate polyketide
chain enoyl- and keto- reduction. Therefore, it was neces-
sary to overexpress pntAB for achieving optimal NADPH
levels to improve FK506 biosynthesis. Similarly, accA2 also
had a large fPH, indicating the pathway as a potential
overexpression target. Overexpressing this gene would in-
crease the precursor (malonyl-CoA) level of FK506.
In addition, Figure 3B also shows that overexpressing
the secondary pathway genes such as fkbABCD, fkbL,
fkbM, fkbO, fkbP, fkbGHIJK, tcsABCD, can improve levels
of FK506 flux, signifying a need for increased metabolic
flux through the secondary pathway. These strategies
can increase the available precursor pool. However, com-
pared with the above targets, these targets showed a little
increase in FK506 production rate since overexpressing
the individual gene may lead to precursor shortage of the
other pathways. Additionally, there existed some difficulty
in multiple genes manipulation. Therefore, genes of the
secondary metabolic pathway were not considered in this
work. The next target was to enhance the PPP through
overexpressing zwf2 gene. In fact, zwf2 also played a key
role in the supply of NADPH for FK506 biosynthesis. In
the zwf2 overexpression strain, the increase in PPP flux in-
dicated an enhanced drain of carbon to erythrose-4-phos-
phate (E4P), direct precursor of shikimate pathway. In
addition, glucose-6-phosphate dehydrogenase (G6PDH)
enhancement by overexpressing zwf2 could result in an
increase in intracellular PPP flux and precursor pool,
thus improving the product titer [29,30]. Lastly, pccB
and metK encoding propionyl-CoA carboxylase and S-
adenosylmethionine synthetase, respectively, were also
predicted to exert a beneficial effect on FK506 produc-
tion. Here, they were not selected for the following gen-
etic modifications, since the former was demonstrated
to result in a limited improvement [8] while the latter
was different from fkbM which remained unknown and
required a more in-depth investigation in future. Fur-
ther simulations, however, showed no other potential
overexpression targets leading to higher FK506 produc-
tion. Therefore, the genes dahp, pntAB, accA2 and zwf2
were identified as overexpression targets for the en-
hanced production of FK506.
Multiple genes knockout-overexpression combinations
simulation
According to the result of single gene knockout or
overexpression simulation, we also attempted to simulate
the effect of multiple genes knockout-overexpression on
the FK506 production and cell growth. Here, gdhA andppc were selected as knockout targets, dahp, pntAB,
accA2 and zwf2 as overexpression targets. Due to the limi-
tation of the algorithm, multiple genes overexpression re-
sults could not be predicted. This was because that when
genes A and B were amplified by 2-fold simultaneously, it
was difficult to control them in the same fold increase in
real experiment (overexpressing a specified gene based on
a ten-copy plasmid did not mean ten-fold the transcrip-
tion level of a one-copy plasmid, nor did it mean ten-fold
the protein amount, nor did it mean ten-fold metabolic
flux value through the reaction). In this study, we simu-
lated gdhA and ppc double knockout, combination of
gdhA (or ppc) and single overexpression. As shown in
Figure 3C, the specific growth rate of gdhA and ppc
double knockout was 0.037 h-1, and the specific FK506
production rate was 6.53 μmol/g DCW/h. When the
single gene knockout combined with the single gene
overexpression, all the mutants showed an increase in the
specific FK506 production rate, compared with the cases
of single gene manipulation (knockout or overexpression).
Besides, the in silico gdhA mutants (HT-ΔGDH-DAHP,
HT-ΔGDH-ACC, HT-ΔGDH-PNT, HT-ΔGDH-ZWF)
displayed higher specific FK506 production rate and
fPH than in silico ppc mutants (HT-ΔPPC-DAHP, HT-
ΔPPC-ACC, HT-ΔPPC-PNT, HT-ΔPPC-ZWF). Espe-
cially, gdhA inactivation and dahp overexpression (in
silico HT-ΔPPC-DAHP) gave rise to the highest fPH.
For double genes knockout combined with single gene
overexpression, it could not further improve the spe-
cific FK506 production rate and fPH.
Experimental validation of predicted targets
Impact of single gene disruption on cell growth and FK506
synthesis
Gene deletion was conducted to experimentally investi-
gate the prediction of the above knockout simulations.
The target genes gdhA and ppc were inactivated by the
kanamycin and thiostrepton resistance cassette, respect-
ively, without affecting the expression of the down-
stream genes.
The positive mutants were confirmed by PCR amplifi-
cation and sequencing of the disrupted region. Results
showed that there was no change in morphological
phenotype between the gdhA or ppc single deletion mu-
tant and the parent strain D852. However, the growth of
HT-ΔGDH strain was slightly affected, with a lower bio-
mass concentration (8.1 ± 0.6 g/L and 3.4 ± 0.1 g/L for 6
d and 3 d, respectively) as compared with the parent
strain D852 (8.9 ± 0.3 g/L and 4.4 ± 0.3 g/L for 6 d and 3
d, respectively) (Figure 4). Additionally, just as expected,
the NADPH-dependent glutamate dehydrogenase (GDH1)
activities of HT-ΔGDH strain at 72 h and 144 h were
assayed to 0.25 ± 0.05 U/mg and 0.13 ± 0.04 U/mg, re-


























































Biomass   3 d  6 d
Figure 4 The effect of single gene knockout and
complementation on FK506 production and cell growth. The
data are the average values of at least three series of three parallel
tests, and error bars represent standard deviations.
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target enzyme was replaced by the resistance cassette.
Nevertheless, it was noted that NADH-dependent glu-
tamate dehydrogenase (GDH2) which also catalyzes α-
ketoglutarate and ammonia to glutamate (Figure 2)
increased from 60.75 ± 5.21 U/mg to 79.55 ± 1.66 U/mg
at 72 h (Table 1). This observation might be ascribed to
the fact that the inactivated GDH1 activity up-regulated
the GDH2 activity for glutamate biosynthesis. The intra-
cellular glutamate decreased, whereas the inactivatedTable 1 Specific activity of enzymes by parent strain S. tsukub
Enzyme activities
(U/mg protein)
Time (h) D852 HT-ΔGDH HT
GDH1 72 55.85 ± 1.36 0.25 ± 0.05 -
144 36.47 ± 1.09 0.13 ± 0.04 -
GDH2 72 60.75 ± 5.21 79.55 ± 1.66 -
144 50.32 ± 3.98 54.67 ± 4.42 -
PPC 72 0.85 ± 0.04 - 0.0
144 0.32 ± 0.11 - 0.1
PK 72 0.86 ± 0.02 - 1.1
144 0.47 ± 0.03 - 0.6
PC 72 2.25 ± 0.22 - 2.4
144 1.77 ± 0.13 - 1.8
DAHP 72 0.15 ± 0.03 - -
144 0.11 ± 0.03 - -
PNT 72 0.07 ± 0.02 - -
144 0.19 ± 0.05 - -
ACC 72 Not detected - -
144 Not detected - -
G6PDH 72 0.13 ± 0.03 - -
144 0.08 ± 0.02 - -
Results are represented as mean ± SD of three independent observations.GDH1 enzyme resulted in intracellular accumulation of
the substrate α-ketoglutarate (Figure 5). As an intermediate
of TCA cycle, α-ketoglutarate could be converted to other
organic acids such as succinate and fumarate. Therefore,
the levels of these TCA intermediates were also improved
as shown in Figure 5. During the batch cultivation, total
sugar consumption rate was decreased by 10%, from 0.49 ±
0.03 g/L/h to 0.44 ± 0.02 g/L/h, while FK506 production
was increased from 143.5 ± 8.7 mg/L to 197.7 ± 7.9 mg/L at
6 d, compared with parent strain D852 (Figure 4). Besides,
the NADPH level in the mutant was enhanced as expected
(Table 2), which revealed the important role of the gdhA
gene in redox cofactor biosynthesis.
As for the ppc mutant strain HT-ΔPPC, the PPC activ-
ity was almost reduced to zero, compared with the value
of the parent strain D852 (0.85 ± 0.04 U/mg at 72 h)
(Table 1), indicating that the enzyme was completely
inactivated. In addition, another anaplerotic pathway en-
zyme pyruvate carboxylase (PC) was slightly increased
for the ppc mutant strain; whereas, the activity of pyru-
vate kinase (PK), which catalyzes the reaction from PEP
to pyruvate, was increased to 1.12 ± 0.03 U/mg at 72 h
in HT-ΔPPC strain, compared with 0.86 ± 0.02 U/mg at
72 h in D852 (Table 1). These observations indicated
that PEP precursor was partially channeled towards the
pyruvate formation and TCA cycle was maintained
through pyruvate anaplerotic pathway. According to the
batch culture profile, the HT-ΔPPC strain exhibited a
longer lag time (24 h compared to 12 h in parent strain),aensis D852 and recombinants in batch cultures
-ΔPPC HT-DAHP HT-PNT HT-ACC HT-ZWF
- - - -
- - - -
- - - -
- - - -
8 ± 0.05 - - - -
0 ± 0.04 - - - -
2 ± 0.03 - - - -
0 ± 0.02 - - - -
9 ± 0.16 - - - -
9 ± 0.12 - - - -
0.26 ± 0.02 - - -
0.19 ± 0.04 - - -
- 0.98 ± 0.02 - -
- 1.69 ± 0.09 - -
- - Not detected -
- - Not detected -
- - - 0.29 ± 0.04
- - - 0.15 ± 0.05
Figure 5 Intracellular metabolite profiles at 72 h for engineered strains. Heat map visualizes most intracellular metabolites from glycolysis,
TCA, PPP and amino acid pathways of engineered strains under the same fermentation condition. The color code indicates an increased (red) or
a decreased (green) availability as compared to the reference wild-type strain D852, as indicated by the color legend as aside the graph.
Availability for each metabolite was calculated as ratio of the concentration of each engineered strain to that of the wild-type strain D852. The
data are the average values of at least five series of five parallel tests.
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6.8 ± 0.2 g/L biomass at 6 d (Figure 4). Despite the
suppressed cell growth, FK506 production were in-
creased to 79.1 ± 10.5 mg/L and 189.8 ± 6.7 mg/L at 3 d
and 6 d, almost 1.4- and 1.3-fold of the parent strain
(55.9 ± 8.9 mg/L and 143.5 ± 8.7 mg/L), respectively. Fur-
thermore, it was worth noting that intracellular PEP and
pyruvate concentration in HT-ΔPPC mutant increasedby approximately 5-fold and 1.8-fold, respectively, com-
pared with D852 (Figure 5), indicating that carbon flux
from PEP node was redistributed and converted to more
precursors (chorismate) for FK506 production.
Besides, the specific FK506 production rate for HT-
ΔGDH strain and HT-ΔPPC strain were 1.88 ± 0.05 and
1.92 ± 0.08 μmol/g DCW/h, respectively, higher than
the parent strain D852 (1.61 ± 0.10 μmol/g DCW/h)
Table 2 Intracellular concentrations of NAD+, NADH, NADP+ and NADPH during exponential growth in batch cultures
Strains Intracellular concentration (μmol/g biomass) NADH/
NAD+ratio
NADPH/
NADP+ratioNAD+ NADH NADP+ NADPH
D852 2.33 ± 0.05 0.85 ± 0.03 0.72 ± 0.04 1.89 ± 0.05 0.36 ± 0.03 2.63 ± 0.22
HT-ΔGDH 1.31 ± 0.05 0.59 ± 0.10 0.65 ± 0.06 3.31 ± 0.09 0.45 ± 0.10 5.09 ± 0.67
HT-ΔPPC 2.67 ± 0.02 0.73 ± 0.06 0.95 ± 0.06 1.38 ± 0.07 0.27 ± 0.03 1.45 ± 0.18
HT-DAHP 2.58 ± 0.02 0.88 ± 0.05 0.68 ± 0.07 1.80 ± 0.02 0.34 ± 0.02 2.65 ± 0.33
HT-PNT 2.55 ± 0.09 0.59 ± 0.04 0.47 ± 0.03 2.19 ± 0.06 0.23 ± 0.03 4.66 ± 0.45
HT-ACC 2.47 ± 0.04 0.95 ± 0.02 0.67 ± 0.07 1.68 ± 0.04 0.38 ± 0.02 2.50 ± 0.37
HT-ZWF 2.35 ± 0.09 0.91 ± 0.04 0.34 ± 0.03 2.28 ± 0.06 0.39 ± 0.03 6.71 ± 0.84
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Figure 6 The effect of single gene overexpression on FK506
production and cell growth. The data are the average values of at
least three series of three parallel tests, and error bars represent
standard deviations.
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dicted value (Figure 3A). Furthermore, to explore the
relationship between the reduced intermediate and cell
growth, we tested the growth of these mutants with
addition of intermediate precursors (glutamate or glu-
tamine for HT-ΔGDH strain, TCA cycle intermediates
such as succinate, fumarate or malate for HT-ΔPPC
strain). Results showed that the mutant strains restored
cell growth (Additional file 4: Figures S1 and S2).
Complementation of the disruption mutants
It was assumed that increased FK506 production was as-
cribed to the accumulation of the precursors in the gdhA
or ppc disruption mutant. To confirm this, complemen-
tation experiments were carried out in the mutant
strains HT-ΔGDH and HT-ΔPPC by introducing gdhA
and ppc, plus their native RBS sites using pIB139
plasmid, respectively. First, a control experiment was
performed that the parent strain D852 was transferred
by pIB139 plasmid. As expected, the control strain HT-
PIB139 produced an unchanged level of FK506 produc-
tion and biomass compared with D852, indicating that
the plasmid did not influence the fermentation cha-
racteristics of the strain D852. Subsequently, the
constructed plasmids pGDH and pPPC were intro-
duced into HT-ΔGDH and HT-ΔPPC, respectively. As
shown in Figure 4, FK506 in both HT-ΔGDH/GDH
and HT-ΔPPC/PPC strains were reduced by 25% than
the corresponding mutant (HT-ΔGDH and HT-ΔPPC)
at 6 d, which was almost the same as those produced
by the parent strain D852. Additionally, the cell growth
was improved but still lower than the level of D852,
which might be due to the metabolic burden to the
host. The above results provided evidence that the
targeted disruption of gdhA or ppc gene correlated with
the increased production of FK506.
Impact of single gene overexpression on cell growth and
FK506 synthesis
To validate the overexpression targets selected by fPH,
the target genes were cloned into pIB139 carrying theermE* promoter and subsequently introduced into the S.
tsukubaensis D852 via conjugation from Escherichia coli
ET12567/pUZ8002 (see details in Materials and methods).
In this section, four positive targets (dahp and accA2 from
Streptomyces roseosporus, pntAB and zwf2 from Strepto-
myces coelicolor) were heterologously overexpressed in S.
tsukubaensis D852.
First, target gene dahp encoding 3-deoxy-D-arabino-
heptulosonate-7-phosphate (DAHP) synthase was over-
expressed in D852. The DAHP synthase activity of the
resulting strain HT-DAHP was 0.26 ± 0.02 U/mg and
0.19 ± 0.04 U/mg at 72 h and 144 h, respectively, ap-
proximately doubled those of wild-type D852 (0.15 ±
0.03 U/mg and 0.11 ± 0.03 U/mg at 72 h and 144 h, re-
spectively) (Table 1), confirming that heterologous dahp
gene functioned well. The cell growth was changed little
for the engineered strain (9.8 ± 0.5 g/L at 6 d) (Figure 6).
Importantly, overexpression of DAHP synthase en-
hanced FK506 production by approximately 50%, up to
216.8 ± 11.9 mg/L at 6 d, compared with the parent
strain D852 (143.5 ± 8.7 mg/L). Accordingly, the specific
FK506 production rate (2.56 ± 0.09 μmol/g DCW/h) for
HT-DAHP was higher than that for the corresponding
Huang et al. Microbial Cell Factories 2013, 12:52 Page 10 of 18
http://www.microbialcellfactories.com/content/12/1/52wild-type D852 (1.61 ± 0.10 μmol/g DCW/h) (Additional
file 3: Table S3), indicating that dahp gene overexpression
played a positive role in FK506 production.
Another predicted gene pntAB encoding membrane-
bound transhydrogenase was also amplified. In Strep-
tomyces, there exist only one membrane-bound
transhydrogenase, instead of two enzymes in E. coli
[31]. The pyridine nucleotide transhydrogenase (PNT)
enzymes are composed of α and β subunits encoded
by the pntA and pntB genes, respectively. In our work,
PNT enzymes were introduced into the native strain.
The specific transhydrogenase activity assay showed
that the HT-PNT possessed 0.98 ± 0.02 U/mg at 72 h,
compared with 0.07 ± 0.02 U/mg in parent strain D852
(Table 1). Besides, the differences in the concentra-
tions of four redox cofactors were observed during the
exponential growth phase (Table 2). The NADPH/NADP+
ratio was approximately 20-fold higher than the NADH/
NAD+ ratio in HT-PNT (Table 2). The NADPH/NADP+
ratio in HT-PNT was increased from 2.63 to 4.66, while
the NADH/NAD+ ratio was decreased from 0.36 to 0.23
compared with D852, indicating that the transhy-
drogenase converted more NADH into NADPH. Fur-
thermore, the concentration of NADPH in HT-PNT
increased, while the concentration of NADH decreased,
compared with D852. However, the total concentration
of four redox cofactors remained unchanged. It should
be noted that biomass synthesis was enhanced up to
10.2 ± 0.4 g/L in HT-PNT. Besides, within 72 h, HT-
PNT produced 83.9 ± 9.9 mg/L FK506 (Figure 6) with
the specific production rate of 2.34 ± 0.11 μmol/g
DCW/h (Additional file 3: Table S1).
The third target gene accA2 was overexpressed in D852,
generating HT-ACC strain. Although the enzyme activity
assay was repeated several times with independent-
prepared extracts, acetyl-CoA carboxylase (ACC) in
mutant strain HT-ACC and the parent strain D852
could not be detected (Table 1), which might be due to
the lower value of detection limit. Even so, the intracel-
lular metabolite profile displayed an expected increase
(approximately three-fold) in intracellular malonyl-CoA
concentration compared with D852 (Figure 5). On the
contrary, the level of acetyl-CoA in HT-ACC was only
25% of the parent strain (Figure 5), suggesting that
overexpressing ACC promoted the transformation of
acetyl-CoA to malonyl-CoA for FK506 biosynthesis.
Moreover, overexpression of accA2 resulted in an ap-
proximately 40% improvement in FK506 production
(200.5 ± 15.1 mg/L at 6 d), in comparison with the levels
in D852 (143.5 ± 8.7 mg/L at 6 d) (Figure 6). Different
from HT-DAHP and HT-PNT, no difference was ob-
served in biomass yield between HT-ACC and D852
(Figure 6), indicating that overexpressing the accA2
gene did not influence the cell growth.The last modification gene zwf2 was chosen as a target
to amplify in D852. As expected, the G6PDH activity of
HT-ZWF at 72 h and 144 h was 0.29 ± 0.04 and 0.15 ±
0.05 U/mg protein, respectively, which was increased by
123.1% and 87.5% compared with D852 (0.13 ± 0.03 and
0.08 ± 0.02 U/mg protein) (Table 1). The fermentation
profiles showed that overexpression of zwf2 resulted in
an approximately 35% improvement of FK506 produc-
tion (up to 193.2 ± 12.1 mg/L at 6 d), whereas a slight
improvement of biomass concentration was achieved in
zwf2 overexpressed recombinant (up to 9.1 ± 0.2 g/L),
compared with D852 (Figure 6). In addition, the glyco-
lytic intermediates such as glycerate-1,3-bisphosphate
and PEP in the mutant strain HT-ZWF decreased by
38% and 25%, respectively, in comparison with D852, as
shown in Figure 5. On the contrary, the corresponding
PPP intermediates such as E4P concentration in HT-
ZWF was about 3-fold higher than that of the parent
strain D852 owing to the increase of enzyme activity of
G6PDH. Moreover, since enhancing the PPP can increase
the intracellular reducing power NADPH, similarly with
HT-PNT, a 33.5% increase in NADPH concentration was
achieved in HT-ZWF (Table 2). The NADPH/NADP+ ra-
tio was also increased from 2.63 to 6.71, but the NADH/
NAD+ ratio was almost kept constant, compared with
D852, indicating that the zwf2 gene overexpression had no
influence on NAD(H) balance.
Effect of combined gene knockout and overexpression on
FK506 synthesis
Since the single knockout or overexpression experiment
improved FK506 production at various levels, the cumu-
lative effect of multiple genetic manipulations on FK506
production was carried out by combining the gene knock-
out and overexpression. Here we explored the perform-
ance of these constructed strains to gain a better
understanding of the underlying mechanisms about which
pathway governed the FK506 biosynthesis. As shown in
Figure 7, when the single gene knockout combined with
the other overexpression genes, the ΔGDH mutants could
produce higher titer of FK506 than that of ΔPPC, consist-
ent with the in silico prediction (Figure 3C). It was sug-
gested that the gdhA inactivation generated a positive
effect in the combined strain. Furthermore, the strains
which possessed an extra pntAB copy produced lower
FK506 than the mutants without it, indicating that the
other genes manipulation have saturated the NADPH
capability available for FK506 production and further
modification may generate the detrimental side effects.
From another perspective, the above results implied that
the redox balance played a key role in FK506 production
and pntAB gene just converted the excess NADH into
NADPH when necessary. Particularly, the strain over-
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Figure 7 The effect of combined gene knockout and overexpression on FK506 production. Plus or minus symbols denote presence or
absence of the indicated gene(s) manipulation. The data are the average values of at least three series of three parallel tests, and error bars
represent standard deviations.
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FK506, a 1.8-fold increase compared with the parent
strain D852. In addition, combination of double knock-
outs by HT-ΔGP resulted in as low as 67% of the FK506
production level achieved by HT-ΔGDH. Moreover,
additional modifications did not further increase FK506
production compared with HT-ΔGDH-DAZ.
Metabolic characterization of HT-ΔGDH-DAZ strain in fed-
batch fermentation
To evaluate the potential FK506 production capacity for
the constructed strain HT-ΔGDH-DAZ, fed-batch fer-
mentation was carried out. Result showed that the
substrate uptake rate and biomass concentration of HT-
ΔGDH-DAZ were 0.44 ± 0.02 g/L/h and 8.5 ± 0.6 g/L,
compared with the parent strain D852 (0.52 ± 0.03 g/L/h
and 10.5 ± 0.7 g/L) (Figure 8A). The HT-ΔGDH-DAZ
accumulated 435.9 ± 18.5 mg/L FK506 during the sta-
tionary phase, 1.47-fold higher than the parent strain
D852 (158.7 ± 11.1 mg/L) (Figure 8B). These results
demonstrated that FK506 biosynthetic performance of
the rational engineered HT-ΔGDH-DAZ strain could be
further improved during the fed-batch fermentation.
Furthermore, it was observed that the production of by-
products FK520 and 37,38-dihydro-FK506 (FK506D) in
HT-ΔGDH-DAZ were also increased by approximately
1.1-fold, up to 45.6 ± 5.8 mg/L and 22.4 ± 4.3 mg/L,
respectively, compared with the values of D852 (21.9 ±
3.5 mg/L and 12.2 ± 3.4 mg/L). It was considered that the
improvement of by-products resulted from the commonprecursors and similar pathways with FK506 under the
same genetic context and culture condition [32].
Discussion
Despite many efforts aimed at optimizing different mi-
croorganisms for industrial FK506 production [8,9],
there has been no report of a genetically engineered
FK506 over-producer that can compete with the trad-
itionally producing strains. GSMM provides an approach
for strain optimization—systems metabolic engineering.
The approach can be used to identify the bottleneck in
the intracellular behaviors thus improve product yield
on the basis of metabolic engineering. Specifically, the
GSMM can facilitate the in silico prediction of previously
unknown key metabolic nodes, thus enable synthesize more
precursors and cofactors towards FK506. In fact, this strat-
egy has been successfully used to identify target genes for
the improvement of biochemical products [23,24,33,34]. In
the present work, the GSMM of S. tsukubaensis were used
to identify gene targets for improved FK506 production.
Among the initially predicted targets, NADPH-
dependent glutamate dehydrogenase encoded by gdhA
and phosphoenolpyruvate carboxylase encoded by ppc
were chosen as knockout targets. The introduced genetic
modification of gdhA influenced several fluxes through
the central carbon metabolism (Figure 2). One of these
flux changes was the reaction supplying cofactor NADPH
for FK506. The pathway has been manipulated to improve
important secondary metabolites such as lycopene and
sesquiterpene [11,35]. Although the gdhA plays a key role
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Figure 8 The production performance profiles of wild-type strain D852 and engineered strain HT-ΔGDH-DAZ in fed-batch
fermentation. (A) Total sugar and biomass profiles; (B) FK506 and by-products profiles. The data are the average values of at least three series of
three parallel tests, and error bars represent standard deviations.
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the carbon flux through GDH2 compensates for the loss
of GDH1. In this study, HT-ΔGDH showed an approxi-
mately 40% increase in FK506 titer compared with
D852. In this regard, deletion of gdhA could lead to a
new redistribution of carbon flux that could be partially
diverted into FK506 biosynthesis instead of glutamate
family biosynthetic pathway, thus acquire an overall in-
crease in yield.
Deletion of ppc reduced the flux from PEP to oxaloac-
etate [36]. Due to a decreased flux through PPC, the net
flux from PEP towards shikimate pathway increased,
which directed more precursors towards FK506 biosyn-
thesis (Figure 2). From this perspective, the substantial
PPC flux in D852 blocked efficient carbon conversion to
DHCHC precursor for FK506 production. Thus, it was
necessary to delete the PPC encoding gene ppc. In fact,
it has been demonstrated that PPC is not an indispensableenzyme in Corynebacterium glutamicum [37]. Besides, in
B. subtilis pyruvate carboxylase can replace PPC to main-
tain the anaplerotic reaction [38]. In our study, the ppc
disruption resulted in an approximately 45% increase in
the final FK506 titer. However, deletion of this gene also
caused a 24% decrease in the biomass compared with
D852, indicating that the pathway exerted a negative effect
on the primary metabolism [39]. Moreover, it was ob-
served that when the two selected knockout genes were
manipulated in combination, the FK506 production de-
creased, compared with the single knockout strain (HT-
ΔGDH or HT-ΔPPC) (Figure 7). It may be primarily
ascribed to the unbalanced metabolism between cell
growth and product formation, which would be explored
in our future research.
In addition, several overexpression targets were identi-
fied using the algorithm raised by [24]. Overexpression
of dahp gene showed an advantageous effect on the final
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estingly, dahp overexpression has been previously ap-
plied to improve balhimycin yields by enhancing
shikimate pathway [40]. However, the yield increment
was not so much as predicted by the algorithm. In
addition to the reasons of prediction, the bottleneck
may be that in the primary metabolism aromatic amino
acid biosynthesis is strictly controlled by feedback
inhibition mechanisms. In E. coli, there are three isoen-
zymes of DAHP synthase, encoded by aroF (tyrosine-
sensitive), aroG (phenylalanine-sensitive), and aroH
(tryptophan-sensitive) [41]. The aroF and aroG can be
inhibited by only 0.1 mM of tyrosine and phenylalanine,
respectively. Thus, it is necessary to apply specific meta-
bolic adaptations to resist feedback inhibition [42].
Fortunately, it has been revealed that some antibiotic
biosynthetic clusters contain another similar gene,
which is not inhibited by aromatic amino acids [43-45].
Therefore, it provides an opportunity to further optimize
FK506 production.
The direct precursors of FK506 biosynthesis are
malonyl-CoA, methylmalonyl-CoA, methoxymalonyl-ACP
and allymalonyl-CoA [7,46,47]. Therefore, the predicted
accA2 gene was overexpressed, as it catalyzed the conver-
sion of acetyl-CoA to malonyl-CoA (Figure 2). In S.
tsukubaensis, the acetyl-CoA pool as well as sources of
malonyl-CoA are limited. Overexpression of ACC en-
hanced the biosynthesis of malonyl-CoA (Figure 5), leading
to the high production of FK506. Overexpression of ACC
has also resulted in an improved malonyl-CoA biosynthesis
and flavanone overproduction [34]. Malonyl-CoA availabil-
ity has been shown to be a rate-limiting factor for many
chain initiation and elongation reactions such as fatty acid,
flavonoid and polyketide biosynthesis [48,49]. These
facts clearly showed the beneficial effect of accA2
overexpression in enhancing the malonyl-CoA pool
available for FK506 biosynthesis.
With the aid of fPH value, targets pntAB and zwf2 were
identified to play an important role in regulating the redox
metabolism. They were both responsible for the provision
of NADPH as a cofactor of FK506 biosynthesis. In order
to improve NADPH availability, a NADP-dependent
glyceraldehyde-3-phosphate dehydrogenase from Clostrid-
ium acetobutylicum was introduced into E. coli to replace
the native NAD-dependent enzyme, which exerted an im-
provement in the lycopene and ε-caprolactone production
[50]. In addition, it was reported that inactivation of the
phosphofructokinase gene (pfkA) directed more carbon
flow towards the PPP, leading to actinorhodin and
undecylprodigiosin overproduction in S. coelicolor A3(2)
[51]. In our work, the zwf2 and pntAB genes were
overexpressed both individually and combinatorially. The
single overexpression strain (HT-PNT or HT-ZWF) pro-
duced an improved FK506 in comparison to wild-typestrain D852. Consequently, it was considered that enhan-
cing NADPH availability may improve flux towards the
FK506 biosynthesis pathway. However, the recombinant
strain HT-PZ expressing both genes showed lower con-
centration than HT-PNT or HT-ZWF (Figure 7). This
may be attributed to the fact that additional redox gene
caused the metabolic imbalance which was closely related
with the energy, amino acids, lipids and nucleotides me-
tabolism [52]. It was indicated that synthesis of FK506
may be strictly regulated by the intracellular NADPH
level. In fact, it has been reported that sufficient NADPH
concentrations and proper redox balance are necessary for
NADPH-dependent biosynthetic processes [53]. Thus, it
seemed that reducing equivalents were not transferred
from NADH to NADPH via PNT in HT-PZ, and the net
reducing equivalents available for FK506 production could
not exceed a certain value. These results demonstrated
that, on one hand, overexpression of gene pntAB or zwf2
increased NADPH availability; on the other hand, a proper
and balanced redox state was necessary for the efficient
FK506 production.
Combination of multiple genes knockout and over-
expression manipulation was also analyzed in this study.
The performance of these strains could aid in under-
standing the relationship between the impact of single
gene manipulation and combinatorial genes manipulation
on the FK506 biosynthesis pathway. As shown in Figure 7,
the gdhA knockout mutants combined with the other
overexpression genes were beneficial to the improvement
of FK506 synthesis, while ppc mutants combinations
enhanced FK506 production to a lesser extent. The ra-
tional designed strain S. tsukubaensis HT-ΔGDH-DAZ
with overexpression of dahp, accA2, zwf2 and deletion of
gdhA was a promising cell factory which may be applied
to produce FK506 efficiently in industry fermentation.
The strain HT-ΔGDH-DAZ displayed a high specific
FK506 production rate (2.65 and 2.74 μmol/g DCW/h for
500-mL flask batch culture and 3-L bioreactor fed-batch
cultivation, respectively). Besides, the genetic stability re-
sult indicated that the hereditary character of the strain
HT-ΔGDH-DAZ was stable. Therefore, in the laboratory-
scale, our engineered strain HT-ΔGDH-DAZ can compete
with traditional overproducers. It was interesting to see
that impact of multiple genes modification on metabolic
characteristic of strain may be related to the interactions
among the interconnected pathways. Recently, this obser-
vation has been clearly elucidated to be the synergistic ef-
fect (positive or negative cooperativity) [54], which would
guide the selection of combinatorial genes modification
for strain optimization.
Based on the experimental validation, the predicted
gene targets directed more carbon flux or redox cofactor
towards FK506 production. However, the observed
improvement in the specific FK506 production rate
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to the predicted improvement. These differences might
be due to the fact that our metabolic network did not
take into account the kinetic and thermodynamic
constraints on the possible flux changes, the interaction
of pathways as well as complex regulatory mechanisms.
Therefore, there existed some limitations in our
constraint-based metabolic model. Even so, the ob-
served improvement in the FK506 production proved
the validity of the metabolic engineering target. The
intracellular metabolite data obtained from this study
can be used to investigate the thermodynamic and kin-
etic parameters of the pathways, which are imposed as
additional constraints on the model for the next round
of metabolic engineering. Besides, since the true path-
way fluxes are still unknown, it is necessary to quantify
intracellular fluxes by 13C-metabolic flux analysis, which
will further improve algorithm predictability.
Conclusions
In this work, the GSMM-guided metabolic engineering
strategy was employed to improve the FK506 production
of S. tsukubaensis. Based on the single gene knockout
and overexpression simulation, potential targets (gdhA
and ppc for knockout; dahp, pntAB, accA2 and zwf2 for
overexpression) were identified. The strains were
designed according to each predicted target. Fermenta-
tion characterization of the engineered strains with sin-
gle gene knockout or overexpression showed the
improved capacities of FK506 production. Moreover,
the combinatorial genes modification indicated that
strain HT-ΔGDH-DAZ with gdhA-deletion and dahp-,
accA2-, zwf2-overexpression produced 435.9 mg/L
FK506 during fed-batch fermentation, 1.47-fold higher
than the parent strain D852 (158.7 mg/L). Our results
demonstrate the validity of application of in silico mod-
elling tools for biopharmaceuticals overproduction. The
intracellular metabolite data would be used for compu-
tational analysis to investigate kinetics and thermody-
namics of the pathways. The precursors or cofactors
availability would be further investigated to regulate the
accumulation of intermediates and to enhance efficient
conversion into FK506. Moreover, since FK506 biosyn-
thetic cluster influenced the titre, enhancing the
catalysed efficiency of the cluster might be essential for
future work.
Materials and methods
Genome-scale metabolic network reconstruction
The procedure of the genome-scale metabolic network
reconstruction for the S. tsukubaensis can be described
as follows. The gene products of S. tsukubaensis were
analyzed and annotated function by sequence alignment
against protein sequences from related organisms basedon the sequence homology search. In this work, a func-
tional sequence by the bidirectional BLASTp was
screened after attaining three thresholds: e-value ≤ 10-30,
matching length ≥ 70% of the query sequence, amino
acid sequence identity ≥ 40%. Various isoenzymes or en-
zyme complexes were identified with KEGG, resulting in
the initial network. Public databases, such as KEGG,
BRENDA, UniProt and MetaCyc, were used to manually
refine the draft metabolic network, including addition of
specific reactions, deletion of incorrect reactions, bal-
ance of mass and charge information, filling of metabolic
gaps. Some reactions which were obtained from the ex-
perimental data and published literature were also
supplemented in the network. Besides, biosynthetic reac-
tions for the biomass and FK506 were included. Since
there was no detailed information on the biomass com-
position of S. tsukubaensis, the protein, DNA, RNA,
lipids, small molecules and cell wall components (pep-
tidoglycan, carbohydrate and teichoic acid) were partly
measured and partly referred from literature data. As for
the FK506 synthesis, the synthesis of specific precursors
and overall reaction were added (Figure 1B). The de-
tailed information of the biomass composition and
FK506 synthesis are described in (Additional file 1: Text
S1). The genes, proteins, reactions, and metabolites are
listed in (Additional file 2: Text S2) in detail.
Computational procedure
The resulting model was analyzed using Constraint-Based
Reconstruction and Analysis (COBRA). Gene knockout or
overexpression prediction was performed using the
COBRAToolbox-2.0 in MATLAB, with GLPK and CPLEX
as the optimization programming solvers [55].
For the knockout targets identification, FBA algorithm
was first employed to obtain an initial flux distribution
with the maximization of the specific growth rate as the
objective function. The constrains contained experimen-
tal specific consumption and production rates. Second,
using MOMA algorithm [16], the knockout targets
which resulted in a higher specific FK506 production
rate than the value of the parent strain D852 were iden-
tified. Here, metabolic flux distribution of knockout
strain changed minimal with respect to the flux distribu-
tion of the parent strain. The knockout targets were
screened according to the in silico specific FK506 pro-
duction rate.
For the overexpression targets identification, the algo-
rithm developed by [24] was employed. In brief, an FBA
problem with the maximization of the specific growth
rate was calculated, generating an initial flux distribution
for the whole network. This step was the same as the
first step of knockout simulation. Subsequently, each
non-zero reaction flux was amplified to some extent (for
instance 2-fold), and the quadratic programming problem
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identified through comparing a fraction value, fPH (the ra-
tio of weighted and dimensionless specific growth rate
and specific FK506 production rate).







Overexpressing genes that had the higher fPH were the
better candidates to manipulate experimentally.
Bacterial strains, plasmids and cultivation conditions
All strains and plasmids used in this study are summa-
rized in (Additional file 5: Table S2). The parent strain S.
tsukubaensis D852 was a stock of our laboratory and de-
posited in China General Microbiological Culture Col-
lection Center with the accession number CGMCC
7180. All Streptomyces mutants were derived from D852.
E. coli JM109 was used to propagate all plasmids. E. coli
ET12567/pUZ8002 was used as the nonmethylating
plasmid donor strain [56] for intergeneric conjugation
with S. tsukubaensis D852. E. coli strains were cultured
in Luria-Bertani (LB) medium at 37°C. The integrative E.
coli–Streptomyces vector pIB139 containing the ermE*
promoter (PermE*) [57] was used for gene overexpression
in S. tsukubaensis D852, and E. coli–Streptomyces vector
pKC1139 [56] was used for in-frame gene knockout.
Spores and seed culture of S. tsukubaensis D852 were
prepared as described by [56,58]. Batch cultivation for
FK506 production was carried out by inoculating 1 mL
of seed culture into 100 mL of production medium in a
500-mL flask at pH 7.0 and then culturing at 220 rpm
for 6 days at 28°C. The production medium contained
60 g/L starch, 2 g/L yeast extract, 2.5 g/L peptone, 5 g/L
soybean meal, 0.5 g/L K2HPO4, 0.5 g/L CaCO3, 0.5 g/L
MgSO4, pH 7.0. Fed-batch fermentation was performed
at 28°C in a 3-L BIOFLO 110 bioreactor (New Brunswick
Scientific Company, USA) with the working volume of 1.5
L. The aeration rate was set to 1 vvm by a mass flow con-
troller. The dissolved oxygen level was kept above 20% of
air saturation by automatically regulating the agitation
speed. The pH was controlled at 6.8 by automatic addition
of 0.5 M HCl and 0.5 M NaOH. Antibiotics were added
appropriately as follows: ampicillin 100 μg/mL, apramycin
50 μg/mL, thiostrepton 20 μg/mL, kanamycin 25 μg/mL
and chloromycin 25 μg/mL. S. coelicolor A3(2) and S.
roseosporus ATCC 11379 were cultivated in YEME for
genomic DNA isolation [56].
Gene cloning, plasmid construction and transformation
All DNA manipulations were performed according to
the standard protocols [59]. All primers used in thiswork are listed in (Additional file 5: Table S3). DAHP
synthase gene (aroH, here we defined dahp) (accession
number ZP_04707751) and ACC gene (accA2) (acces-
sion number ZP_04710929) were amplified from S.
roseosporus ATCC11379 genomic DNA. PNT gene
(pntAB) (accession number CAC16724 and CAC16725)
and G6PDH gene (zwf2) (accession number CAB50762)
were amplified from S. coelicolor genome. Each gene was
digested by NdeI–XbaI and cloned into pIB139 to yield
pDAHP, pACC, pPNT, pZWF, respectively.
To delete the BamHI restriction site, pUC18 was
excised with BamHI, linearized, blunt-ended and ligated,
generating pUC18M. For the construction of pDP carry-
ing double genes, PCR product of dahp was excised with
NdeI–XbaI and transferred to the same sites of
pUC18M, generating pUC18M-D. Then PCR product of
pntAB was digested with BglII–XbaI and transferred to
the BamHI–XbaI sites of pUC18M-D, generating
pUC18M-DP. The NdeI–XbaI fragment of the dahp and
pntAB genes were excised from the pUC18M-DP and li-
gated into pIB139 to yield pDP. The other plasmids
pDA, pDZ, pPA, pPZ and pAZ were constructed using
the similar method. For the plasmids construction of
three genes overexpression, pUC18M-DP, pUC18M-DA
and pUC18M-PA were digested with BamHI–XbaI and
ligated with BglII–XbaI of PCR product containing the
accA2, zwf2 gene, respectively, yielding pUC18M-DPA,
pUC18M-DPZ, pUC18M-DAZ and pUC18M-PAZ. Then
the resulting plasmids were excised with NdeI–XbaI and
the long fragment containing the three genes were trans-
ferred to the same sites of pIB139. The plasmid pUC18M-
DPA was excised with BamHI–XbaI and ligated with
BglII–XbaI of PCR product containing the zwf2 gene. The
generated pUC18M-DPAZ was excised with NdeI–XbaI
and inserted into the same sites of pIB139. Each
constructed plasmid was transferred into E. coli ET12567/
pUZ8002, which was subsequently introduced into S.
tsukubaensis D852 through conjugal transfer [56]. The
positive exconjugants were verified by PCR amplification
and DNA sequencing with primer pair pIB-F/pIB-R.
To delete NADPH-dependent GDH1 gene gdhA, dele-
tion plasmid was constructed by amplifying the up-
stream and downstream flanking regions from genomic
DNA of S. tsukubaensis (accession number EIF89180).
the upstream and downstream flanking regions of gdhA
were amplified using the primers gdhA-LF/gdhA-LR and
gdhA-RF/gdhA-RR, respectively. The above two frag-
ments were excised with XbaI–BamHI and KpnI–EcoRI,
respectively, ligated sequentially into the pUC119-KanR
which possessed the kanamycin resistance cassette. After
digestion with the restriction enzymes XbaI–EcoRI, the
fragments were ligated into pKC1139 that had been
digested with the same restriction enzymes, resulting in
the deletion plasmid pΔGDH (Additional file 5: Table S3).
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D852 using the procedure as described above. The double
crossover mutant was selected as described previously
[32], verified by PCR amplification and DNA sequencing.
As for PPC gene ppc, the method was similar with the
gdhA with the exception that thiostrepton resistance
cassette was used as the selected marker.
For complementation experiment, the pGDH and
pPPC plasmids were constructed according to the pro-
cedure similar with the pDAHP and subsequently intro-
duced into the HT-ΔGDH and HT-ΔPPC, respectively.
Analytical methods
The biomass was determined by filtering 10 mL fermen-
tation broth through a pre-weighed 0.45 μm pore size
filter (Satorius), washing twice and drying at 80°C to
constant weight. The residual total sugar in fermentation
broth was quantified using phenol-sulfuric acid method
[60]. For the detection of FK506 as well as the by-
products FK520 and FK506D, the sample was mixed
with equal volume of methanol, shaken intermittently in
water bath at 50°C for 2 h. After centrifugation at 6,000 ×
g for 10 min, the supernatant was analyzed by HPLC
equipped with a Venusil XDB-C18 column (5 μm, 250
mm× 4.6 mm). The mobile phase contained 0.1% phos-
phoric acid in water and acetonitrile (35:65, v/v). The flow
rate was 1 mL/min, the column temperature was 60°C
and the detection wavelength was 210 nm.
Quantification of intracellular metabolites
The intracellular metabolites were determined in the ex-
ponential phase in batch cultivations by triplicate. For
each point, 10 mL of culture broth was immediately fil-
tered through a 0.8 μm pore size cellulose acetate mem-
brane. On the filter disc, the cells were subsequently
washed with 10 mL 0.9% (w/v) NaCl solution. Next, the
filter was immediately transferred into a 50 mL tube
containing 25 mL of pre-chilled methanol solution (60%,
v/v) (−40°C) to stop cell metabolism. The above procedure
was controlled within 10–15 s. Subsequently, the mixture
was centrifuged at 3,000 × g for 10 min at −20°C. After re-
moving the supernatant, 2.5 mL cold aqueous methanol
solution (60%, v/v, −40°C) was added to the sample tube
and stored at −80°C until metabolites extraction. The me-
tabolites were extracted by thawing the above samples in
an ice bath for 4 min. Then the mixture was vigorously
shaken for 1 min and frozen for 30 min at −80°C. After re-
peating three times of freeze-thaw, the sample was then
centrifuged at 10,000 × g for 10 min at −20°C and the
supernatant was used for quantifying metabolites. Intra-
cellular metabolites of central carbon metabolism (glycoly-
sis, PPP and TCA cycle) and cofactors were determined
by liquid chromatography-tandem quadrupole mass spec-
trometry, as described by [61]. Amino acids and CoAesters were measured by gas chromatography–mass
spectrometry and liquid chromatography-electrospray
ionization-tandem mass spectrometry, as described by
[62] and [63], respectively. The measurements of intracel-
lular metabolites were normalized to the biomass.
Analysis of in vitro enzyme activities
The culture samples were harvested at the exponential
phase (72 h) and the stationary phase (144 h), and pre-
pared as our previous procedures [30]. The standard assay
for DAHP synthase activity was spectrophotometrically
(549 nm) monitored by following the oxidation with
NaIO4 and reaction with thiobarbituric acid at 100°C [64].
As a membrane-bound protein, the PNT activity was
determined in cell extracts without centrifugation. The
activity of PNT was measured spectrophotometrically at
375 nm by the reduction of 3-acetylpyridine-NAD+ as
reported previously [65]. ACC activity was measured as
described by [66]. G6PDH activity assay was performed
based on the NADPH synthesis according to the method
of [67]. GDH1 and GDH2 were determined by oxidizing
NADPH or NADH at 340 nm in the presence of α-
ketoglutarate and ammonia [68]. PPC activity was mea-
sured spectrophotometrically by monitoring the oxidation
of NADH in a coupled assay with malate dehydrogenase
[69]. PK activity was monitored by the decrease in absorb-
ance of NADH at 340 nm, with lactate dehydrogenase as
the coupling enzyme [70]. PC was assayed by coupling the
oxidation reaction of NADH with malate dehydrogenase
towards the oxaloacetate synthesis and measured spectro-
photometrically at 340 nm [71]. Total protein concentra-
tions were quantified by Bradford assay with a reagent
solution (Quick Start Bradford Dye, BioRad). The assays
of enzyme activities were normalized to the total protein.
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